MIST

Milestone Pharmaceuticals Inc. Common Shares

0.79

USD

-0.07

-7.78%

Sep 24, 15:59 UTC -4

Closed

Pre-Market

0.80

0.00

+0.14%

Milestone Pharmaceuticals Inc. Common Shares Profile

About

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr?al, Canada.

Info & Links

CEO

Joseph Oliveto

Headquarters

1111 DR. FREDERIK-PHILIPS BOULEVARD, SUITE 420
MONTREAL, A8 H4M 2X6, CANADA

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

Milestone Pharmaceuticals Inc. Common Shares Statistics

Valuation Measures

Market Capitalization²

99.10M

Enterprise Value

-11.42M

Enterprise Value/EBITDA(ttm)

0.14

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

6.29

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

47.10%

Operating Margin(ttm)

Profit Margin(ttm)

-4017.72%

Return on Equity(ttm)

-288.33%

Return on Invested Capital(ttm)

-97.75%

Return on Assets(ttm)

-58.27%

Income Statement

Revenue(ttm)

797.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

751.00K

EBITDA(ttm)³

-79.75M

Net Income Available to Common(ttm)

-84.01M

Diluted EPS(ttm)

-0.69

Share Statistics

Beta (5Y Monthly)

0.98

52-Week Change

-59.03%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

124.50M

Dividend Yield

0.00%

Float⁴

118.24M

% Held by Insiders

5.03%

% Held by Institutions

86.18%

Balance Sheet

Total Cash(mrq)

170.61M

Total Cash Per Share(mrq)

1.37

Total Debt(mrq)

59.21M

Total Debt/Equity(mrq)

324.99%

Current Ratio(mrq)

8.13%

Quick Ratio(mrq)

7.92%

Book Value Per Share(mrq)

0.15

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.28

Free Cash Flow(ytd)

-38.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.